Absci is trading 5.9% up at $10.01, with no clear company-specific announcement identified to explain the intraday move. - Its October 27, 2026 announcement scheduled participation in upcoming investor conferences. - Broader markets were mixed; the provided index moves did not show a strong, same-direction rally clearly accounting for Absci’s gain. - Recent coverage highlighted an AstraZeneca collaboration and upcoming ABS-201 data, but neither establishes a direct cause for today’s move.